These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 26492953)

  • 21. [Evaluation of cardiovascular risk by the LAP index in non-obese patients with polycystic ovary syndrome].
    Costa EC; Sá JC; Soares EM; Lemos TM; Maranhão TM; Azevedo GD
    Arq Bras Endocrinol Metabol; 2010 Oct; 54(7):630-5. PubMed ID: 21085768
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dietary glycemic index is associated with less favorable anthropometric and metabolic profiles in polycystic ovary syndrome women with different phenotypes.
    Graff SK; Mário FM; Alves BC; Spritzer PM
    Fertil Steril; 2013 Oct; 100(4):1081-8. PubMed ID: 23830153
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The impact of intensified exercise training on insulin resistance and fitness in overweight and obese women with and without polycystic ovary syndrome.
    Harrison CL; Stepto NK; Hutchison SK; Teede HJ
    Clin Endocrinol (Oxf); 2012 Mar; 76(3):351-7. PubMed ID: 21711376
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Obese adolescents with polycystic ovarian syndrome have elevated cardiovascular disease risk markers.
    Patel SS; Truong U; King M; Ferland A; Moreau KL; Dorosz J; Hokanson JE; Wang H; Kinney GL; Maahs DM; Eckel RH; Nadeau KJ; Cree-Green M
    Vasc Med; 2017 Apr; 22(2):85-95. PubMed ID: 28095749
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Plasma interleukin-18 levels are increased in the polycystic ovary syndrome: relationship of carotid intima-media wall thickness and cardiovascular risk factors.
    Kaya C; Pabuccu R; Berker B; Satiroglu H
    Fertil Steril; 2010 Mar; 93(4):1200-7. PubMed ID: 19131059
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Independent predictors of cardiovascular risk in polycystic ovarian syndrome.
    Türkçüoğlu I; Kafkasli A; Meydanli MM; Ozyalin F; Taşkapan C
    Gynecol Endocrinol; 2011 Nov; 27(11):915-9. PubMed ID: 21294689
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The Role of Follicular Fluid Thiol/Disulphide Homeostasis in Polycystic Ovary Syndrome.
    Tola EN; Köroğlu N; Ergin M; Oral HB; Turgut A; Erel Ö
    Balkan Med J; 2018 Jul; 35(4):306-310. PubMed ID: 29636312
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Association of sympathovagal imbalance with cardiovascular risks in patients with polycystic ovary syndrome.
    Kuppusamy S; Pal GK; Habeebullah S; Ananthanarayanan PH; Pal P
    Endocr Res; 2015; 40(1):37-43. PubMed ID: 24866562
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dynamic thiol/disulphide homeostasis as a novel indicator of oxidative stress in obese children and its relationship with inflammatory-cardiovascular markers.
    Elmas B; Karacan M; Dervişoğlu P; Kösecik M; İşgüven ŞP; Bal C
    Anatol J Cardiol; 2017 Nov; 18(5):361-369. PubMed ID: 28761018
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Association of heme oxygenase-1 with the risk of polycystic ovary syndrome in non-obese women.
    Gao H; Meng J; Xing H; Nie S; Xu M; Zhang S; Jin Y; Sun T; Huang H; Zhang H; Wang D; Liu L
    Hum Reprod; 2014 May; 29(5):1058-66. PubMed ID: 24585089
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Serum pigment epithelium-derived factor is elevated in women with polycystic ovary syndrome and correlates with insulin resistance.
    Yang S; Li Q; Zhong L; Song Y; Tian B; Cheng Q; Qing H; Xia W; Luo M; Mei M
    J Clin Endocrinol Metab; 2011 Mar; 96(3):831-6. PubMed ID: 21209034
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of various adiposity indexes in women with polycystic ovary syndrome and normo-ovulatory non-hirsute women: a population-based study.
    Ramezani Tehrani F; Minooee S; Azizi F
    Eur J Endocrinol; 2014 Aug; 171(2):199-207. PubMed ID: 24816947
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of hypocaloric diet plus sibutramine treatment on hormonal and metabolic features in overweight and obese women with polycystic ovary syndrome: a randomized, 24-week study.
    Florakis D; Diamanti-Kandarakis E; Katsikis I; Nassis GP; Karkanaki A; Georgopoulos N; Panidis D
    Int J Obes (Lond); 2008 Apr; 32(4):692-9. PubMed ID: 18071341
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Obesity, free testosterone, and cardiovascular risk factors in adolescents with polycystic ovary syndrome and regularly cycling adolescents.
    Glueck CJ; Morrison JA; Friedman LA; Goldenberg N; Stroop DM; Wang P
    Metabolism; 2006 Apr; 55(4):508-14. PubMed ID: 16546482
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A novel method for determining the relation between nasal polyposis and oxidative stress: the thiol/disulphide homeostasis.
    Şimşek E; Erel O; Bicer CK; Çarlıoğlu A
    Acta Otolaryngol; 2016 Nov; 136(11):1180-1183. PubMed ID: 27222940
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Association of serum glypican-4 levels with cardiovascular risk predictors in women with polycystic ovary syndrome - a pilot study.
    Jędrzejuk D; Lwow F; Kuliczkowska-Płaksej J; Hirnle L; Trzmiel-Bira A; Lenarcik-Kabza A; Kolackov K; Łaczmański Ł; Milewicz A
    Gynecol Endocrinol; 2016; 32(3):223-6. PubMed ID: 26486309
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The cardiovascular risk of young women with polycystic ovary syndrome: an observational, analytical, prospective case-control study.
    Orio F; Palomba S; Spinelli L; Cascella T; Tauchmanovà L; Zullo F; Lombardi G; Colao A
    J Clin Endocrinol Metab; 2004 Aug; 89(8):3696-701. PubMed ID: 15292291
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Assessment of paraoxonase 1, xanthine oxidase and glutathione peroxidase activities, nitric oxide and thiol levels in women with polycystic ovary syndrome.
    Baskol G; Aygen E; Erdem F; Caniklioğlu A; Narin F; Sahin Y; Kaya T
    Acta Obstet Gynecol Scand; 2012 Mar; 91(3):326-30. PubMed ID: 22168506
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Is the plasma anti-Müllerian hormone (AMH) level associated with body weight and metabolic, and hormonal disturbances in women with and without polycystic ovary syndrome?
    Skałba P; Cygal A; Madej P; Dąbkowska-Huć A; Sikora J; Martirosian G; Romanik M; Olszanecka-Glinianowicz M
    Eur J Obstet Gynecol Reprod Biol; 2011 Oct; 158(2):254-9. PubMed ID: 21752527
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The effects of rosiglitazone and metformin on oxidative stress and homocysteine levels in lean patients with polycystic ovary syndrome.
    Yilmaz M; Bukan N; Ayvaz G; Karakoç A; Törüner F; Cakir N; Arslan M
    Hum Reprod; 2005 Dec; 20(12):3333-40. PubMed ID: 16123091
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.